Showing results (481-490 of 601) with videos related to

Sort By:
Pageof 61
Journal of Clinical Psychopharmacology|April 28, 2026
Toward Precision Psychiatry: Using Clinical and Pharmacokinetic Data to Increase Antidepressant Dose or Change Treatment in Late-Life DepressionHelena K Kim, Xiaoyu Men, Samar S M Elsheikh, et al.
Therapeutic Advances in Psychopharmacology|May 23, 2022
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping reviewRaghunath Singh, Nicolette Stogios, Emily Smith, et al.
The American Journal of Psychiatry|January 11, 2017
Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older AdultsVictoria S Marshe, Malgorzata Maciukiewicz, Soham Rej, et al.
Neuropsychobiology|April 1, 2019
Investigation of the Gut Microbiome in Patients with Schizophrenia and Clozapine-Induced Weight Gain: Protocol and Clinical Characteristics of First Patient CohortsIlona Gorbovskaya, Sarah Kanji, Jonathan C W Liu, et al.
Psychological Medicine|October 5, 2019
Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 reportTrisha Chakrabarty, Kate L Harkness, Shane J McInerney, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|November 19, 2016
Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gainArun K Tiwari, Danning Zhang, Jennie G Pouget, et al.
The Pharmacogenomics Journal|November 23, 2024
Polygenic score analyses on antidepressant response in late-life depression, results from the IRL-GRey studySamar S M Elsheikh, Victoria S Marshe, Xiaoyu Men, et al.
Pharmacological Research|February 3, 2005
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatmentVincenzo De Luca, John B Vincent, Daniel J Müller, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 14, 2026
Association Between Venlafaxine Exposure And Treatment Outcomes In Older Adults With Depression: Association entre l'exposition à la venlafaxine et les résultats du traitement chez les personnes âgées atteintes de dépressionXiaoyu Men, Zachary L Taylor, Victoria S Marshe, et al.
Psychiatry Research|January 18, 2006
Genetic association analysis of the glutathione peroxidase (GPX1) gene polymorphism (Pro197Leu) with tardive dyskinesiaTakahiro Shinkai, Daniel J Müller, Vincenzo De Luca, et al.
Pageof 61